Related Experiment Video
Updated: Jun 23, 2026
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Pediatric body composition analysis with dual-energy X-ray absorptiometry
Maura Helba1, Larry A Binkovitz
1Department of Radiology, Nationwide Children's Hospital, 700 Children's Way, Columbus, OH 43205, USA.
Pediatric Radiology
|May 6, 2009
Summary
Body composition analysis (BCA) using dual-energy X-ray absorptiometry (DXA) is increasingly vital for pediatricians managing obesity and anorexia nervosa. DXA precisely measures fat and lean tissue mass, aiding in the identification and treatment of these conditions in children.
Area of Science:
- Pediatric Endocrinology
- Body Composition Analysis
- Medical Imaging
Background:
- Increasing prevalence of pediatric obesity and anorexia nervosa necessitates accurate assessment tools.
- Body composition analysis (BCA) is gaining traction among specialists for identifying, treating, and preventing these conditions.
- Dual-energy X-ray absorptiometry (DXA) is a key BCA method for pediatric applications.
Purpose of the Study:
- To review the strengths and limitations of DXA as a pediatric BCA method.
- To evaluate the utility of DXA in assessing fat mass (FM) and lean tissue mass (LTM) in children.
- To explore DXA's role in identifying trends in FM and LTM in obese and anorexic pediatric populations.
Main Methods:
- Review of existing literature on DXA for pediatric body composition analysis.
- Evaluation of DXA's accuracy in quantifying regional and whole-body FM and LTM.
- Analysis of DXA data in the context of pediatric obesity and anorexia nervosa.
Main Results:
- DXA is a widely used and precise method for pediatric BCA, quantifying FM, LTM, and bone mineral content (BMC).
- DXA offers the advantage of precise regional FM and LTM quantification.
- The review assesses DXA's effectiveness in tracking FM and LTM variations in pediatric obesity and anorexia.
Conclusions:
- DXA is a valuable tool for pediatricians in managing childhood obesity and anorexia nervosa.
- Understanding DXA's strengths and limitations is crucial for accurate pediatric body composition assessment.
- DXA facilitates the identification of trends and variations in body composition critical for clinical decision-making in children.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24X-ray Imaging
German physicist Wilhelm Röntgen (1845–1923) was experimenting with electrical current when he discovered that a mysterious and invisible "ray" would pass through his flesh but leave an outline of his bones on a screen coated with a metal compound. In 1895, Röntgen made the first durable record of the internal parts of a living human: an "X-ray" image (as it came to be called) of his wife’s hand. Scientists worldwide quickly began their own experiments with X-rays, and by 1900, X-ray was widely...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...